Imaging and Clinicopathologic Features of Esophageal Gastrointestinal Stromal Tumors

被引:30
作者
Winant, Abbey J. [1 ,2 ]
Gollub, Marc J. [2 ]
Shia, Jinru [3 ]
Antonescu, Christina [3 ]
Bains, Manjit S. [4 ]
Levine, Marc S. [5 ]
机构
[1] Weill Cornell Med Coll, Dept Radiol, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Thorac Surg, New York, NY 10065 USA
[5] Hosp Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA
关键词
barium esophagogram; CT; esophageal neoplasms; esophagus; gastrointestinal stromal tumor; PET; LEIOMYOMA; CRITERIA; AFIP; KIT;
D O I
10.2214/AJR.13.11841
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The purpose of this article is to describe the imaging and clinicopathologic characteristics of esophageal gastrointestinal stromal tumors (GISTs) and to emphasize the features that differentiate esophageal GISTs from esophageal leiomyomas. MATERIALS AND METHODS. A pathology database search identified all surgically resected or biopsied esophageal GISTs, esophageal leiomyomas, and esophageal leiomyosarcomas from 1994 to 2012. Esophageal GISTs were included only if imaging studies (including CT, fluoroscopic, or F-18-FDG PET/CT scans) and clinical data were available. RESULTS. Nineteen esophageal mesenchymal tumors were identified, including eight esophageal GISTs (42%), 10 esophageal leiomyomas (53%), and one esophageal leiomyosarcoma (5%). Four patients (50%) with esophageal GIST had symptoms, including dysphagia in three (38%), cough in one (13%), and chest pain in one (13%). One esophageal GIST appeared on barium study as a smooth submucosal mass. All esophageal GISTs appeared on CT as well-marginated predominantly distal lesions, isoattenuating to muscle, that moderately enhanced after IV contrast agent administration. Compared with esophageal leiomyomas, esophageal GISTs tended to be more distal, larger, and more heterogeneous and showed greater IV enhancement on CT. All esophageal GISTs showed marked avidity (mean maximum standardized uptake value, 16) on PET scans. All esophageal GISTs were positive for c-KIT (a cell-surface transmembrane tyrosine kinase also known as CD117) and CD34. On histopathology, six esophageal GISTs (75%) were of the spindle pattern and two (25%) were of a mixed spindle and epithelioid pattern. Five esophageal GISTs had exon 11 mutations (with imatinib sensitivity). Clinical outcome correlated with treatment strategy (resection plus adjuvant therapy or resection alone) rather than risk stratification. CONCLUSION. Esophageal GISTs are unusual but clinically important mesenchymal neoplasms. Although esophageal GISTs and esophageal leiomyomas had overlapping imaging features, esophageal GISTs tended to be more distal, larger, more heterogeneous, and more enhancing on CT and were markedly FDG avid on PET. Given their malignant potential, esophageal GISTs should be included in the differential diagnosis of intramural esophageal neoplasms.
引用
收藏
页码:306 / 314
页数:9
相关论文
共 21 条
[1]   Malignant gastrointestinal stromal tumor: Distribution, imaging features, and pattern of metastatic spread [J].
Burkill, GJC ;
Badran, M ;
Al-Muderis, O ;
Thomas, JM ;
Judson, IR ;
Fisher, C ;
Moskovic, EC .
RADIOLOGY, 2003, 226 (02) :527-532
[2]   Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: Proposal of new computed tomography response criteria [J].
Choi, Haesun ;
Charnsangavej, Chuslip ;
Faria, Silvana C. ;
Macapinlac, Homer A. ;
Burgess, Michael A. ;
Patel, Shreyaskumar R. ;
Chen, Lei L. ;
Podoloff, Donald A. ;
Benjamin, Robert S. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) :1753-1759
[3]   Malignant Gastrointestinal Stromal Tumors of the Small Intestine: A Review of 50 Cases From a Prospective Database [J].
Jacqueline A. Crosby ;
Charles N. Catton ;
Aileen Davis ;
Jean Couture ;
Brian O’Sullivan ;
Rita Kandel ;
Carol J. Swallow .
Annals of Surgical Oncology, 2001, 8 (1) :50-59
[4]   The GIST of targeted cancer therapy:: A tumor (Gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571) [J].
DeMatteo, RP .
ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (09) :831-839
[5]   Two hundred gastrointestinal stromal tumors - Recurrence patterns and prognostic factors for survival [J].
DeMatteo, RP ;
Lewis, JJ ;
Leung, D ;
Mudan, SS ;
Woodruff, JM ;
Brennan, MF .
ANNALS OF SURGERY, 2000, 231 (01) :51-58
[6]  
Kindblom LG, 1998, AM J PATHOL, V152, P1259
[7]   Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours [J].
Lasota, J. ;
Miettinen, M. .
HISTOPATHOLOGY, 2008, 53 (03) :245-266
[8]  
Levine MS, 2008, TXB GASTROINTESTINAL, P447
[9]   From the archives of the AFIP - Gastrointestinal stromal tumors: Radiologic features with pathologic correlation [J].
Levy, AD ;
Remotti, HE ;
Thompson, WM ;
Sobin, LH ;
Miettinen, M .
RADIOGRAPHICS, 2003, 23 (02) :283-304
[10]   Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis [J].
Miettinen, M ;
Lasota, J .
VIRCHOWS ARCHIV, 2001, 438 (01) :1-12